MAPK and subsequently stimulated expression of GAB2 and FN1, which in turn promoted tumor invasion. We thus identify let-7g as a unique member of the let-7 miRNA family which can serve as a prognostic biomarker in breast cancer and also propose a paradigm utilized by specific signaling molecules via let-7g to cooperatively promote breast cancer invasion and metastasis. Thus, let-7 family members neither possess equivalent clinicopathologic correlation nor function in breast cancer.
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The human let-7 miRNA family consists of 13 members located in 8 genomic locations frequently deleted in human cancers (6) . Nine distinct mature let-7 miRNAs with identical seed sequences are produced from 12 precursor sequences from miRBase (7) . Aberrant expression of let-7 miRNA has been associated with poor prognosis of several types of cancer (8) (9) (10) (11) . For example, expression of let-7 miRNAs is reduced in non-small-cell lung cancer patients and associated with poor prognosis (12) , and increased expression of let-7a substantially reduces tumor burden in a K-Ras murine lung cancer model (13) .
While let-7 is widely viewed as a tumor suppressor miRNA, upregulation of certain let-7 family members has also been observed (6) , although less frequently.
While let-7 family members were generally believed to have overlapping targets and therefore redundant roles, whether individual members of the let-7 family possess specific roles in cancer development and metastasis is largely undefined (6, 14) . Author Manuscript Published OnlineFirst on August 25, 2011; DOI: 10.1158/0008-5472. CAN-11-1322 In this report, amongst all mature let-7 miRNAs in the let-7 family, let-7g was identified as the only one, reduced expression of which correlates with worse survival outcome in breast cancer patients. GAB2 and FN1 were identified as the novel targets of let-7g which increased activity of p44/42 MAPK and MMP-2/MMP-9. Estrogen and EGF specifically reduced let-7g expression and increased expression of GAB2 and FN1. We therefore propose a model whereby estrogen and EGF promote breast cancer metastasis through several feedback loops via the specific interplays between let-7g and its downstream cascades. Author Manuscript Published OnlineFirst on August 25, 2011; DOI: 10.1158/0008-5472. CAN-11-1322 Cell lines and Cell culture. All human breast cancer cell lines used in this study were obtained from the American Type Culture Collection (Rockville, MD) and cultured in conditions as recommended. All cells were maintained in a humidified incubator at 37℃ and 5% CO 2. Detection of miRNA expression by in situ hybridization in formalin-fixed paraffin-embedded (FFPE) tissues . For detecting expression of let-7g family miRNAs in invasive mammary carcinoma and normal mammary tissues, ISH was performed as previously described (16) cDNA using SuperScript® III Reverse Transcriptase (Invitrogen). All available TaqMan miRNA assays were used for expression analysis as indicated. For mRNA analysis, cultured cells were used for extraction of mRNA using TRIzol® Plus RNA Purification system. SYBR Premix Ex Taq Kit (Takara) was used to determine the expression levels of GAB2, FN1 and other analyzed genes (Table   S5 ). The relative amount of gene transcripts was normalized to GAPDH.
Materials and Methods
Gelatin zymography. Activity of MMP-2 and MMP-9 was measured by the method of gelatin zymography as previously described (17) with several modifications. Conditioned media were obtained by incubation of MCF cells with serum-free medium for 24 h, and was then concentrated 80-fold using Amicon Ultra Centrifugal Filter Units (Millipore) and normalized by protein concentrations.
Samples were loaded on 10% SDS-PAGE gels containing 0.1% gelatin.
Electrophoresis was performed under non-reducing conditions at 100 V and 4°C. Gels were washed in 2.5% Triton X-100, incubated in substrate buffer (50 mM Tris-HCl, pH 8.0/50 mM NaCl/10 mM CaCl 2 /0.05% Brij 35) for 40 h at 37°C, stained with Coomassie stain solution (Bio-Rad), and destained in 20% methanol, 10% acetic acid. Gelatinolytic activity was identified as a clear band on a blue background. Reduced let-7g expression is prognostic for poor survival of breast cancer patients. In order to specifically define let-7 miRNA species involved in mammary carcinoma progression, we utilized digoxigenin (DIG)-labeled locked nucleic acid (LNA)-miRNA probes to detect abundance of 9 mature let-7 miRNAs in archived breast cancer specimens (BC, n=86) and breast tissue specimens from patients with benign breast diseases (BD, n=21) using in situ hybridization (ISH). (15, 16) . The expression of let-7 miRNAs were detected predominantly within the cytoplasm of the benign luminal epithelial cells or carcinoma cells (Fig.   1A , S1A). Of all the let-7 miRNAs examined and graded double-blindly, we observed significantly diminished expression of only let-7a, c and g (Fig. 1A) in BC compared to normal specimens (P=0.031, Table S1 *C ). The association between the expression of all let-7 family members and clinicopathologic characteristics of BC and this data is summarized in Table S2 *A . Table S5 ; Fig. 1C , Table S5 ). In contrast, the expression levels of none of the remaining eight miRNAs could predict survival outcome in BC patients ( We next examined let-7g expression in fresh mammary carcinoma specimens by qPCR analysis using stem-looped miRNA-specific reverse transcription primers and TaqMan probes. The expression level of let-7g was significantly lower in BC patients with lymph node metastases, compared to those from patients with no detectable lymph node metastases (Fig. 1D ).
Results
However, the expression level of neither let-7d nor let-7f miRNA exhibited significant differences between the BC patient cohorts with or without lymph node metastases ( Fig. S1B, S1C ),.
We also examined the relative expression of let-7g in benign breast tissue, premalignant proliferative lesions and mammary carcinoma specimens by ISH (Fig. 1E) . Interestingly, progressively reduced expression of let-7g was observed from normal breast epithelium to DCIS (ductal carcinoma in situ) to IDC (invasive ductal carcinoma), supporting a role of reduced expression of let-7g in both the initiation and progression of breast cancer. Finally, we examined the relative expression of let-7g in an array of mammary epithelial and mammary carcinoma cell lines using qPCR (Fig. S1D) . The highest expression levels of let-7g were observed in two immortalized but otherwise normal HMECs, whereas low or undetectable levels of let-7g expression were observed in highly invasive mammary carcinoma cell lines (such as MDA-MB-231 and MDA-MB-468). In comparison, expression levels of let-7d (Fig.S1E ) and let-7f ( (Fig. S2A, S2B ). Let-7g ASO exhibited a high specificity to deplete its own target sequence but did not appreciably deplete other let-7 miRNAs by using qPCR analysis. (Fig. 2A) .
Let-7g depletion in low invasive MCF-7 cells led to a more rapid closing of the wound (Fig. S2C ) and a potent increase in cell migration and invasion than the control cells (Fig. 2B) . Conversely, forced expression of let-7g in the highly invasive MDA-MB-231 cells resulted in retarded wound closing ( Fig. S2D ) and significant reduction in cell migration and invasion (Fig.2C) . The same experimental approach was adopted in two other mammary carcinoma cell lines (low invasive T47D and highly invasive MDA-MB-468) ( Fig. S2E-S2H ).
let-7g depletion initiates distant metastasis in vivo.
We further determined were of particular interest among the candidate genes, as both have been implicated in breast cancer metastasis in animal models and the clinical setting (23) (24) (25) (26) (27) (28) (29) . Both the GAB2-encoded mRNA and FN1-encoded mRNA contain a 3'UTR element that is partially complementary to let-7g and carries the identical sequence in the multiple mammalian mRNA orthologues (Fig. S3A, S3C ).
Forced expression of let-7g reduced the activity of a luciferase reporter gene containing the 3'UTR of GAB2 (Fig. 3A) , indicating that let-7g directly targets GAB2. We further identifed a single let-7g cognate binding site, LCS2, within the GAB2 3'-UTR, was the major target site for let-7g and thereby sufficient to regulate GAB2 expression (Fig. 3A, S3B) . Consistently, forced expression of let7g diminished GAB2 expression at both mRNA and protein levels (Fig. 3B) , indicating GAB2 is a bona fide target of let-7g.
We further determined whether GAB2 was required for let-7g mediated mammary carcinoma cell motility. Specific depletion of GAB2 by siRNAs significantly abrogated let-7g depletion enhanced MCF-7 cell motility (Fig. 3C, 3D S3E, S3F,). The functional importance of the interaction between let-7g and GAB2 3'UTR was also determined by utilizing either full length GAB2 (ORF plus 3'UTR) with or without mutation at LCS2. Thus, GAB2 is a critical mediator for the let-7g depletion enhanced cell migration and invasion (Fig. 3E) .
Similarly, we identified FN1 as a direct target of let-7g and mapped the major let-7g binding site within the FN1 3'-UTR (Fig. 3F, 3G, S3C, S3D ). We Indeed, let-7g depletion potently increased the expression and activity of MMP-2/-9 ( Fig. 4B, 4C) . Furthermore, abrogation of GAB2 expression by specific siRNAs diminished the expression and enzymatic activity of MMP-2/-9 consequent to let-7g depletion (Fig. 4B, 4C) . Similarly, we demonstrated that FN1 expression was required for the increased MMP-2/-9 expression and invasion consequent to let-7g depletion (Fig. S3G ). To further demonstrate that MAPK activity was required for the increased MMP-2/-9 activation, let-7g depleted MCF-7 cells were treated with either the MEK1/2 specific inhibitor U0126 or MMP-2/MMP-9 specific inhibitor SB-3CT. Inhibition of MEK1 activity was demonstrated to be sufficient to diminish MMP-2/MMP-9 activity and let-7g depletion promoted cell motility (Fig. 4D, 4E ). It is apparent that the p44/42 MAPK-MMP-2/-9 pathway was utilized to enhance cell migration and invasion consequent to let-7g depletion.
GAB2 and FN1 are preferentially targeted by let-7g for p44/42 MAPK activation. We next sought to determine why let-7g depletion alone should possess such striking biological effects and its cellular context in breast cancer metastasis. To answer both questions, we sought to determine possible differential effects of let-7g depletion on cell behavior compared to the depletion of other let-7 family members. Let-7d ASO and let-7f ASO were included as controls and the specificity of each ASO for the three let-7 miRNAs was first determined by qPCR (Fig. 5A) . Let-7d and let-7f were chosen as controls for full functional analyses as let-7d with a four-nucleotide difference to let-7g would represent a distant structural control and let-7f with only a two-nucleotide difference would represent a closer structural control. Functionally, let-7g depletion was more potent to promote the migration and invasion of MCF-7 cells compared to the depletion of either let-7d or let-7f (Fig. 5B) 
depletion exhibited significantly higher efficacy to promote cancer cell migration and invasion.
Mechanistically, let-7g more potently inhibited the activity of 3'-UTRluciferase constructs for GAB2 or FN1 genes, compared to let-7d or let-7f in two types of cells (Fig. 5C, S4H) ; Consistently, let-7g ASO also more potently increased the activity of 3'-UTR-luciferase construct for GAB2 or FN1 genes in comparison to let-7d or let-7f (Fig. 5D) . The effect of forced expression of all of the different let-7 family members on the 3'UTR of GAB2 and FN1 is presented in Fig S3. H. Concordantly, we observed that the expression level of let-7g but not let-7d or let-7f negatively correlated with GAB2 or FN1 mRNA level in an array of breast epithelial cell lines (Fig. S4B-S4G ). GAB2 and FN1 were therefore preferentially targeted by let-7g in mammary carcinoma cells. Consistently we demonstrated that let-7g depletion but not for let-7d or let-7f depletion potently increased the expression of GAB2 or FN1 and significantly activated p44/42 MAPK (Fig. 5E ). We therefore propose that increased GAB2 and FN1 consequent to let-7 depletion represents an integrated modulation of the p44/42 MAPK pathway specific for let-7g but not for the other let-7 miRNAs examined.
The functional specificity of let-7g demonstrated herein was highly consistent with our clinical studies that only decreased expression of let-7g significantly correlated with proliferative status, lymph node metastasis and prognosis of breast cancer patients (Tables S2, S5 ). CAN-11-1322 metastasis, such as estrogen and EGFR/HER2 ligands, might contribute to promotion of mammary carcinoma cell invasion through regulation of let-7g expression.
Treatment of MCF-7 cells with 17 β-estradiol (E2) resulted in rapid and specific reduced let-7g expression (Fig. 6A, 6B, S5A, S5B ). E2 increased GAB2 expression at both the mRNA and protein level (Fig. 6B, 6C ). The specificity of E2 treatment via ERα was verfied by using Fulvestrant (Fig. 6D) . Transfection of the let-7g mimic substantially abrogated the effect of E2 on GAB2 expression, indicating that E2 stimulated GAB2 expression via the interaction between let-7g and GAB2 3'-UTR (Fig. 6E) . We further demonstrated that estrogen promoted migration and invasion of MCF-7 ( Fig. 6F ) and T47D cells (Fig. S5C) via let-7g depletion and elevated GAB2 expression.
Similarly, the effects of EGF on let-7g and GAB2 expression and cell motility were also detected. EGF promoted mammary carcinoma cell migration and invasion (Fig. 6I, S5D ) through let-7g depletion and consequently increased GAB2 expression (Fig. 6G-6L ) via EGFR/HER2 (Fig. 6J) . Thus, both E2 and EGF reduced let-7g expression and consequently increased GAB2 expression, leading to enhancement of cell migration and invasion.
Similarly, we demonstrated that FN1 expression was increased by E2 and EGF via their repression of let-7g expression (Fig. S5E-S5H ). Increased FN1 expression was also required for E2 and EGF stimulation promoted mammary carcinoma cell migration and invasion via let-7g repression (Fig. S5I, S5J ).
We also determined what pathways might mediate E2 and EGF promoted The aberrant expression of miRNAs in cancer progression has previously been determined mostly by microarray profiling, bead-based technologies and quantitative real-time PCR in either fresh or archived formalin-fixed paraffinembedded tumor specimens or blood samples. However, these approaches are inevitably confounded by the heterogeneity of the bio-specimens, especially the cell population of the tumor microenvironment including stromal and inflammatory cells. This is probably one explanation for the substantial conflicting data in the field (37). For example, miR-10b has been reported pro-metastatic (38, 39) or anti-metastatic (40, 41) in breast cancer independently by multiple groups. In this study, the expression of the entire let-7 family miRNAs were examined in clinical specimens by ISH with clinicopathological analysis. Strikingly, reduced expression of let-7g in mammary carcinoma was uniquely linked with tumor metastasis and poor patient survival. The functional significance of this negative correlation was further supported by in vitro and in vivo studies (Fig. 2) . We have therefore identified a unique member of the let-7 family as an independent prognostic marker for breast cancer. It is of interest to note that let-7g has also been reported to play a unique role among the let-7 family members in the irradiation response of lung cancer (43) .
Contrary to other let-7 miRNAs, only let-7g exhibited an increased expression in response to gamma irradiation in three lung cancer cell lines. However, the mechanism whereby let-7g played the unique role in lung cancer was not determined.
In this study, we demonstrated that E2 and EGF, major pro-metastatic growth GAB2 mRNA (top two panels) and protein (bottom two panels) were detected. C, the efficacy of GAB2 siRNA was verified by either RT-PCR (top two panels) or western blot (bottom two panels). D, let-7g depletion promoted cell migration and invasion was diminished by GAB2 silencing. E, Let-7g depletion promoted cell migration and invasion was mediated by its interaction with the 3'UTR of GAB2. Estrogen-deprived and serum-deprived MCF-7 cells were pretreated with MEK specific inhibitor U0126 for half an hour and followed by 6 hr treatment with E2 or EGF. The expression levels of mature let-7g were measured by qPCR. EGF+let-7g
Figure Legends
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on August 25, 2011; DOI: 10.1158/0008-5472.CAN-11-1322Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on August 25, 2011; DOI: 10.1158/0008-5472.CAN-11-1322
